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a4 Integrins Regulate the
Proliferation/Differentiation Balance
of Multilineage Hematopoietic Progenitors In Vivo
marrow, although erythropoiesis and myelopoiesis can
also occur in the spleen in mouse.
Interactions with the microenvironment play impor-
tant roles during hematopoiesis (Dorshkind, 1990). a4
integrins mediate binding to a specific region (CS-1) on
Alicia G. Arroyo,*³ Joy T. Yang,*§
Helen Rayburn,* and Richard O. Hynes*²
*Howard Hughes Medical Institute
Center for Cancer Research
and Department of Biology
Massachusetts Institute of Technology fibronectin (FN), to VCAM-1, and to MAdCAM-1 (Hynes,
Cambridge, Massachusetts 02139 1992; Wagner and MuÈ ller, 1998). a4 integrins are devel-
opmentally regulated during hematopoiesis; they are
expressed on early immature multipotent progenitors,
Summary but expression is downregulated during erythrocyte
and neutrophil differentiation (Hemler and Lobb, 1995).
We investigated roles of a4 integrins during hemato- Moreover, a4 integrins can mediate adhesion of hemato-
poiesis using mutant and chimeric mice. Yolk sac poietic progenitors to stromal cells likely through bind-
erythropoiesis and migration of hematopoietic pro- ing to VCAM-1 (Verfaille et al., 1991; Williams et al, 1991;
genitors to fetal liver, spleen, and bone marrow can Papayannopoulou et al, 1995). a4 integrins might also
occur without a4 integrins. Although terminal differen- regulate migration, homing, and proliferation of hemato-
tiation of these progenitors is possible without a4 inte- poietic progenitors (Papayannopoulou and Nakamoto,
grins, these receptors are essential to maintain normal 1993; Coulombel et al., 1997).
hematopoiesis in fetal liver, spleen, and bone marrow a4 integrins have been shown to participate in erythro-
microenvironments. Moreover, a4-deficient erythroid cyte development (reviewed by Hanspal, 1997). a4 and
progenitors and pre-B cells neither transmigrate be- a5 integrins are expressed on early erythroid progeni-
neath the stroma nor expand properly in vitro. In con- tors, being downregulated during erythrocyte differenti-
trast, a4-null cells migrate and differentiate efficiently ation together with the loss of attachment to fibronectin
into T lymphocytes within the thymus. In summary, a4 (Vuillet-Gaugler et al., 1990). Antibodies against a4 or a5
integrins are essential for normal development of all integrins block the attachment of erythroid precursors to
hematopoietic lineages in fetal liver, bone marrow, and FN, and anti-a4 antibodies block migration and differen-
spleen, likely by regulating the proliferation/differenti- tiation of progenitors in vitro (Yanai et al., 1994; Goltry
ation balance of hematopoietic progenitors. and Patel, 1997). The injection of anti-a4 antibodies in-
trautero in mice has also implicated a4 integrins during
erythropoiesis in vivo (Hamamura et al., 1996).Introduction
a4 integrins also seem to participate in regulating the
development of other hematopoietic lineages. In vitroHematopoiesis requires continuous migration, prolifera-
studies with antibodies have shown inhibition of lym-tion, and differentiation of pluripotent progenitors into
phoid colonies, blockade of B cell differentiation, andthe different blood cell lineages (Ogawa, 1993; Morrison
delay in myelopoiesis (Miyake et al., 1991; Ryan et al.,et al., 1995). Colonization of all hematopoietic organs
1992). Roles for a4 integrins at different stages of T celloccurs early in development from a single intraembry-
development in the thymus have also been suggestedonic source, the paraaortic splanchnopleura and its
(Crisa et al., 1996).derivative, the aorta-gonad-mesonephros (AGM) region,
Despite these studies, the detailed functions of a4where multipotent progenitors are detected before em-
integrins during hematopoiesis in vivo remain unclear.bryonic day 8.5 ([E8.5]; Delassus and Cumano, 1996).
Previous characterization of a4-deficient chimeric miceIn mouse, primitive nucleated erythrocytes develop in
(Arroyo et al., 1996) showed that a4 integrins are essen-the yolk sac before that stage. After E10, definitive pluri-
tial for postnatal lymphoid development in the bone mar-potent progenitors are found in the fetal liver, thymus,
row and suggested that embryonic requirements for a4bone marrow, and spleen, but active hematopoiesis be-
integrins during hematopoiesis might be different. Thegins at different times, depending on the development of
present study extends the analysis to other lineageseach hematopoietic environment. In spite of a common
and to earlier stages of development. The results revealprecursor for primitive erythropoiesis and definitive he-
a key role for a4 integrins during hematopoietic develop-matopoiesis (Kennedy et al., 1997), it is clear that the
ment and underscore the functions of a4 integrins inrequirements for their development are different (re-
regulating the proliferation/differentiation balance of he-viewed by Shivdasani and Orkin, 1996). After birth, eryth-
matopoietic progenitors in vivo.ropoiesis, myelopoiesis, B lymphopoiesis, and genera-
tion of T lymphocyte progenitors take place in the bone
Results
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livers from otherwise well developed a4-null embryos
were consistently smaller, paler, and more fragile than
their wild-type and heterozygous counterparts (Figure
2A). The number of nucleated fetal liver cells in a4-
null embryos was significantly lower at E11.5 and E12
compared with wild-type and heterozygotes (Figure 2B).
This suggests a defect in erythropoiesis, since, at that
stage, erythroid cells account for most of the liver cells.
Cytospins from a4-null fetal livers at E12 showed a higher
ratio of proerythroblasts to erythroblasts (a4-null 5 2.2
and wt 5 0.6; n 5 3, p 5 0.002) as well as decreased
cellularity and smaller cellular aggregates compared
with wild-type samples (Figure 2C). However, nonnucle-
ated erythrocytes were observed in the blood and fetal
livers of a4-null embryos (data not shown), indicating
that erythroid terminal differentiation in the fetal liver
can occur in the absence of a4 integrins, albeit less
efficiently. To test whether the defect observed might
be due to impairment in erythroid progenitor activity,
colony assays were performed. Comparable relative
numbers of CFU-e colonies were obtained with E11.5
and E12 fetal liver cells from wild-type, heterozygous,
and a4-null embryos (Figure 2D), suggesting no defects
at the progenitor level.
To investigate later stages of development, circum-
venting early lethality due to the a4-null mutation, chime-
ric embryos (a42/2 ES cells injected into C57BL or RAG-
22/2 blastocysts) were analyzed. Terminal differentiation
of erythrocytes was assessed by analyzing b-globin iso-
forms derived from the donor (Hbbd) and recipient cells
Figure 1. a4 Integrins Are Not Essential for Yolk Sac Erythropoiesis (Hbbs) in the chimeras (Whitney, 1978). a4-deficient cells
In Vivo
differentiate into mature red blood cells (Hbbd) at all
(A and B) Histology of yolk sacs from wild-type (A) and a4-null stages of embryonic development (Figure 3A). The per-
embryos (B) at E11.5 stage shows no major differences in blood
centage contribution of a4-null ES cells to the matureisland distribution and composition (arrows). At least five embryos
erythroid population is, however, lower than that of wild-of each genotype were analyzed. Bar, 166 mm.
type ES cells in control chimeras, and it decreases grad-(C) Yolk sac cells from wild-type, heterozygous, and a4-null embryos
at E9.5 stage were used for colony assays in the presence of differ- ually from E14 to E18 (Figures 3A and 3B).
ent cytokines. Assays were run in duplicate. No significant differ- The defect observed in erythroid development could
ences (BFU-e p 5 0.18 and CFU-mix p 5 0.36) were found in the be due either to a defect in erythroid progenitor cells or
absolute yield of colonies. The total number of yolk sac cells was
to a defect in the fetal liver microenvironment. Fetal liversimilar in embryos from the different genotypes. The mean and
cells of chimeric embryos at E14 were analyzed by flowSD of two to three littermates of each genotype are shown. One
cytometry, staining for expression of a4 integrins andexperiment out of two is presented.
Ter-119, a specific erythroid marker (Figures 3B and
3C). Since expression of a4 integrins is regulated during
yolk sacs from null and wild-type, suggesting that eryth- erythroid development, being positive at early stages
ropoiesis occurs normally in the absence of a4 integrins and downregulated later, we observed only a small pop-
(Figures 1A and 1B). Cytospins from a4-null and wild- ulation of Ter-1191a42 cells, corresponding to late nor-
type embryos at E11.5 displayed a similar pattern of moblasts in control chimeras (Figures 3B and 3C). How-
nucleated red blood cells (data not shown). ever, significantly higher percentages of Ter-1191a42
Colony assays on yolk sac cells from wild-type, het- cells are present in fetal livers from a4-null chimeric
erozygous, and a4-null embryos at E9.5 showed no sta- embryos at E14, E16, and E18 compared with controls
tistically significant differences in the number or mor- (Figures 3B and 3C). Cytospins showed that a majority
phology of colonies obtained (Figure 1C), and a4-null of these Ter-1191a42 cells were early erythroid cells
yolk sac cells gave rise to both erythroid and myeloid (data not shown). Therefore, a4-deficient cells contrib-
lineages (data not shown). Therefore, a4 integrins are ute to the early erythroid population at all stages of
not essential for yolk sac erythropoiesis in vivo. embryonic development but are unable to differentiate
efficiently into mature erythrocytes.
a4 Integrins Play an Important Role in Erythropoiesis Colony assays in the presence of G418 (to select for
in the Fetal Liver a4-null-derived colonies) were also performed. The per-
Definitive hematopoiesis starts in the fetal liver at E10. centage of G418-resistant fetal liver a4-null BFU-e colo-
Since most a4-null embryos die after E12 (Yang et al., nies at E18 was proportional to the percentage of a4-
1995), fetal liver erythropoiesis was studied before that null cells that contributed to other tissues in the chimera,
stage. Fetal livers from a4-null embryos at E10 did not estimated by GPI analysis (Figure 3D). These results
show any significant differences from wild-type (Yang showed no significant reduction of progenitors at late
stages of embryonic development. Thus, in contrast toet al., 1995; data not shown). However, after E11, fetal
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a defect in the ability of a4-null progenitor cells to mature
into erythrocytes in vivo (Figure 3A), BFU-e colony
assays showed that a4-null progenitor cells were able
to differentiate and form colonies in vitro. These results
suggest that the in vivo defects observed are not due
to defects in the a4-null erythroid progenitor cells per
se but more likely depend on interactions of these cells
with the microenvironment.
Myeloid and B Lymphoid Progenitors Require
a4 Integrins for Efficient Development
in the Fetal Liver
The development of other hematopoietic lineages in the
absence of a4 integrins was analyzed. Cytospin prepa-
rations showed myeloid cells in fetal livers from a4-null
embryos at E12 (Figure 4A). E12 a4-null fetal liver cells
give rise to erythroid and myeloid lineages including
macrophages, granulocytes, and sparse megakaryo-
cytes in CFU-mix colony assays (data not shown) and
to pre-B lymphoid cell lines indicating that myeloid and
B lymphoid progenitors are present in the fetal livers
in the absence of a4 integrins. Differentiation of these
progenitors in vivo was assessed by flow cytometry
with the myeloid markers Gr-1 (granulocyte) and Mac-1
(myeloid) and the B cell marker B220 versus the strain-
specific markers Ly-9.1 or Ly-5.2 in chimeric embryos.
Myeloid and B lymphoid differentiation is possible in the
absence of a4 integrins since Ly-5.21 a4-null-derived
Mac-1, Gr-1, and B220-positive cells were all detected
in the fetal livers of a4-null chimeric embryos. However,
the percentage of a4-deficient cells contributing to my-
eloid and B lymphoid lineages is significantly lower than
the controls (Figure 4B), suggesting a requirement for
a4 integrins to maintain normal myeloid and B lymphoid
differentiation in the fetal liver.
The population of progenitors was also analyzed at
E18. CFU-mix colony assays in the presence of G418
show percentages of a4-deficient resistant colonies
roughly proportional to the contribution in other tissues
estimated by GPI analysis, suggesting no defect at the
progenitor level (Figure 4C). Moreover, the colonies con-
tained mature erythrocytes, macrophages, polymorpho-
nuclear cells, and megakaryocytes, indicating that these
progenitors can complete terminal differentiation in
vitro. The contribution of a4-null ES cells to the colonies
was better than to the mature myeloid population in vivo
(B) The number of cells is significantly lower in fetal livers from a4-
null embryos at E12 (p 5 0.0002) compared with wild-type and
heterozygous littermates. Similar results were observed at E11.5
(p 5 0.002; data not shown).
(C) Cytospin preparations of a4-null fetal liver cells show (1) the
presence of erythroid cells at different stages of differentiation with
an increase in the ratio between immature proerythroblasts (arrow-
heads) and maturing erythroblasts (arrows) compared with wild-
type littermates; (2) a decrease in cellularity; and (3) smaller size of
the cellular aggregates. Bar, 166 mm.
(D) Fetal liver cells from wild-type, heterozygous, and a4-null E11.5
and E12 embryos were used for erythroid colony assays. Experi-
ments were run in duplicate. No significant differences (p 5 0.32)
are found in the relative number of CFU-e colonies obtained. The
Figure 2. Fetal Livers Are Smaller in the Absence of a4 Integrins mean and SD of two embryos of each genotype from the same litter
Due to Impairment in Erythroid Development are represented. One experiment out of three is shown. a4-null cells
(A) Fetal livers from E12 a4-null embryos are smaller and paler than also gave rise to BFU-e colonies although no accurate quantitation
their wild-type and heterozygous littermates. Bar, 2 mm. was possible (data not shown).
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Figure 3. Erythroid Progenitors Are Present
in the Fetal Liver in the Absence of a4 Inte-
grins but They Require a4 Integrins for Effi-
cient Differentiation In Vivo
(A) Terminal erythroid differentiation in chime-
ric mice was assessed by analysis of b-globin
isoforms (Hbbd and Hbbs) characteristic of
129Sv (ES cells) or C57BL (recipient blasto-
cysts), respectively. Differentiation of eryth-
rocytes is possible in the absence of a4 inte-
grins at E14 but decays at later stages (E16
and E18) compared with control mice. Com-
parison of embryos with similar percentage
of chimerism estimated by GPI is shown at
each stage (E14 5 85 and 30%; E16 5 65%;
E18 5 75%).
(B) Analysis of Ter1191a42 expression in fetal
liver cells and the percentage of b-globin iso-
forms in blood from wild-type and a4-null chi-
meric embryos at different stages of develop-
ment. Chimeric embryos in C57BL (circles)
and RAG-22/2 (squares) were analyzed. Only
embryos with .30% chimerism were ana-
lyzed. There was no significant difference in
the percent of chimerism between a4-null
and wild-type chimeric embryos (Figure 4C).
(C) Flow cytometry analysis of fetal liver cells
for the expression of the erythroid marker
Ter-119 and a4 integrins. Note that the per-
centage of Ter1191a42 cells is significantly
higher in a4-null chimeras than in controls at
E14; 90% chimeric embryos are shown. Bar,
166 mm.
(D) The presence of erythroid progenitors at E18 was tested by BFU-e colony assays with fetal liver cells from a4-null chimeric embryos in
the presence of 1.5 mg/ml G418. SD within duplicates was less than 10%. One experiment out of two is shown. Fetal liver cells from wild-
type chimeras did not survive in the presence of G418.
at E18 (Figure 4B), suggesting that the in vivo defects a4-null progenitors at E16 (Figure 5B), suggests an ad-
vantage for T cell differentiation in the absence of a4depend on interactions with the microenvironment. It is
also possible to obtain G418-resistant pre-B cells from integrins at early stages of embryonic development.
fetal livers of a4-null chimeric embryos at E18, sug-
gesting that the defect observed in B lymphoid develop- Definitive Hematopoiesis in Spleen and Bone Marrow
Is Severely Compromised in the Absencement at late stages is not due to a deficit of progenitors
(data not shown). All these data demonstrate that a4- of a4 Integrins
Hematopoietic progenitors colonize the bone marrowdeficient myeloid and B lymphoid progenitors are able
to complete terminal differentiation in vivo and in vitro and spleen at E12±13, although active hematopoieis is
not detected until E15 (Delassus and Cumano, 1996).but their capacity to develop in vivo is impaired when
they lack a4 integrins. Previous data showed a defect in postnatal lymphopoie-
sis in the bone marrow in the absence of a4 integrins
and suggested different requirements for a4 integrinsa4 Integrins Are Not Essential for T Lymphocyte
Development in the Thymus in prenatal versus postnatal hematopoiesis (Arroyo et
al., 1996). We therefore explored hematopoietic devel-during Embryonic Life
At E10.5, hematopoietic progenitors migrate to the thy- opment in the bone marrow and spleen around the criti-
cal point of birth.mus, where they differentiate into mature T lymphocytes
(Jotereau et al., 1987). T lymphocyte development was Multipotent progenitors are present in BM and spleen
of a4-null chimeric embryos at E18 assessed by in vitroanalyzed by flow cytometry of thymus from chimeric
embryos. Staining with T cell (Thy-1 and CD4) and strain- colony assays (data not shown). Differentiation of these
progenitors in vivo was analyzed by flow cytometry withspecific (Ly-9.1 or Ly-5.2) markers showed good num-
bers of a4-null-derived thymocytes, indicating that a4- markers for myeloid (Gr-1) and B lymphoid (B220) lin-
eages. As shown in Figure 6A, a4-deficient cells fromdeficient cells can migrate and differentiate efficiently
into T lymphocytes within the thymic microenvironment spleens of chimeric embryos at E18 contribute to Gr-
11 myeloid and B2201 B lymphoid population at per-at all embryonic stages analyzed (Figures 5A and 5B). No
major differences were found in CD42CD82, CD41CD81, centages close to, although significantly lower than,
control wild-type chimeras (average percent contribu-CD41CD82, and CD42CD81 subsets or in the histology
of the thymus when a4-null chimeric embryos were com- tion [n 5 8]: a4-null/Gr-1 5 11.2 and wt/Gr-1 5 31.4,
p 5 0.01; a4-null/B220 5 15.7 and wt/B220 5 38.4, p 5pared with controls (data not shown). At E14, the thymi
of a4-null of chimeras seemed to be consistently larger 0.02). Similar results were observed in the bone marrow
(average percent contribution [n 5 6]: a4-null/Gr-1 5 20than controls. This observation, together with the sig-
nificantly higher percentage of CD41 cells derived from and wt/Gr-1 5 41.5, p 5 0.03; a4-null/B220 5 14.3 and
Roles of a4 Integrins during In Vivo Hematopoiesis
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wt/B220 5 24, p 5 0.1) (data not shown). These results
suggest that a4-deficient progenitors can migrate to
the spleen and bone marrow microenvironments and
complete differentiation.
The roles of a4 integrins in erythropoiesis at perinatal
and postnatal stages were also studied. b-globin analy-
sis shows that a4-null cells in chimeric mice younger
than 1 week can develop into mature erythrocytes (4/6)
although the percentage contribution is lower than in
control chimeras (Figure 6B). However, 0/38 a4-null chi-
meric mice older than 1 week showed any a4-deficient
mature erythrocytes compared with wild-type (15/21),
a5-null (4/6), and av-null (4/4) control chimeric mice (Fig-
ure 6B; data not shown). These data demonstrate that a4
integrin-mediated interactions are essential for normal
erythroid development in the bone marrow and spleen
microenvironments, since a complete blockade of post-
natal erythropoiesis occurs in vivo in the absence of
these receptors. However, in vitro colony assays in the
presence of G418 show that bone marrow and spleen
from 3-month-old a4-null chimeras (40%±50% chime-
rism) contained up to 25% resistant BFU-e and CFU-
mix colonies, suggesting that the failure in erythroid
development was not due to a complete deficit in pro-
genitors but to a defect at later steps of differentiation.
Similar results were obtained when myeloid and B
lymphoid development were studied at perinatal and
postnatal stages. Figure 6C shows that a4-null chimeras
younger than 1 month have a detectable population
of maturing myeloid and B lymphoid cells in the bone
marrow. The percentages are, however, significantly
lower than the controls. In contrast, in a4-null chimeras
older than 1 month, almost no B lymphoid cells and few
myeloid cells are developing in the bone marrow, and
subsequently the numbers of mature cells in blood and
spleen are low in contrast to control chimeric mice (Fig-
ure 6C; Arroyo et al. 1996; data not shown).
These data indicate that a4 integrins are essential for
postnatal multilineage hematopoietic development in
vivo, since erythroid, myeloid, and B lymphoid develop-
ment are severely compromised in the bone marrow and
spleen in the absence of these receptors.
a4 Integrins Are Essential for Transmigration
and Proliferation of Hematopoietic
Progenitors In Vitro
To elucidate the mechanisms responsible for the defects
observed in the absence of a4 integrins, two in vitro
approaches were used.
First, in vitro erythropoiesis assays were performed.
As shown in Figure 7A, fetal liver a4-null cells attach to
bone marrow stroma at day 1 like controls. However,
a4-null primary colonies gave only tiny reddish colonies
Figure 4. Myeloid and B Lymphoid Progenitors Are Present in the
Fetal Liver in the Absence of a4 Integrins, but They Require a4 represented. Every symbol represents an individual mouse. The
Integrins for Efficient Differentiation In Vivo percentage of chimerism of the embryos was estimated by GPI
analysis of the tail and was not statistically different between con-(A) Histological analysis of fetal livers from a4-null embryos at E12
shows the presence of mature myeloid forms (arrowhead). Bar, 166 trols and a4-null chimeras; only mice with .30% chimerism were
analyzed.mmB).
(B) Summary of analyses of the contribution of wild-type and a4- (C) The presence of mixed progenitors at E18 was tested by CFU-
mix colony assays with fetal liver cells from a4-null chimeric embryosdeficient cells to myeloid (Mac-1 and Gr-1) and B lymphoid (B220)
lineages in fetal liver assessed by flow cytometry. Chimeric embryos in the presence of 1.5 mg/ml G418. SD within duplicates was less
than 10%. One experiment out of two is shown. Fetal liver cells fromin C57BL (circles) and RAG-22/2 (squares) were analyzed. The per-
centage contribution of ES cells to the total specific population is wild-type chimeras did not survive in the presence of G418.
Immunity
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Figure 5. a4-Deficient Cells Differentiate Normally into T Lympho-
cytes in the Thymus during Embryonic Development
(A) Staining of thymocytes from control and a4-null chimeric em-
bryos with Thy-1 (T cell±specific) versus Ly-5.2 (strain-specific) is
shown at E16 and E18 stages of development. Embryos of similar
percentage of chimerism (40% at E16 and 55% at E18) are com-
pared.
(B) Summary of the contributions of wild-type and a4-null cells to
T lymphocyte population (Thy-11 or CD41) at E16 and E18. The
percentage contribution to the total population is represented. Every
symbol represents an individual mouse. The percentage of chime-
rism of the embryos was estimated by GPI analysis of the tail; only Figure 6. a4-Null Definitive Progenitors Migrate to Spleen and Bone
mice with .30% chimerism were analyzed. Averages of the different Marrow, but They Fail to Contribute to Erythroid, Myeloid, and
groups and statistical significance are shown. Lymphoid Lineages after Perinatal Stage
(A) Flow cytometry of spleen cells at E18 for myeloid (Gr-1) and B
lymphoid (B220) lineages versus the strain-specific marker Ly-5.2.
Note that there is good contribution of a4-deficient cells to theseby day 4, and no cells were observed beneath the
lineages. Embryos of about 55% chimerism are shown.stroma, whereas wild-type cells transmigrate beneath
(B) b-globin analysis of blood from chimeric mice at perinatal and
the stroma, expand, and develop into large, red erythroid adult stage. Although some contribution is observed at perinatal
colonies. Thus, a4-null erythroid progenitors cultured stage, no contribution of a4-null cells is detected in older chimeras.
under conditions resembling in vivo interactions with (C) Flow cytometry of bone marrow cells from chimeric mice with
the myeloid (Mac-1) versus strain-specific (Ly-5.2) and B lymphoidstroma can complete terminal differentiation (reddish
(B220 and IgM) markers shows a low but consistent perinatal contri-colonies), but the yield of mature erythrocytes is greatly
bution of a4-null cells. However, 1 month after birth the contributiondiminished due to a defect in transmigration and prolifer-
of a4-deficient cells decreases and becomes almost undetectable
ation. compared with controls. Mice of about 70% chimerism are shown.
Second, IL-7-dependent pre-B lymphoid cell lines
were derived from fetal livers from wild-type and a4-null
E12 embryos. Flow cytometry of wild-type and a4-null cell
Roles of a4 Integrins during In Vivo Hematopoiesis
561
lines showed that most cells expressed the pan-B cell
marker B220 and low levels of IgM but they differed
in a4 integrin expression (data not shown). Kinetics of
attachment, transmigration, and proliferation of these
cell lines showed that a4-deficient cells were very ineffi-
cient in attaching and transmigrating beneath the bone
marrow stroma (Figure 7B), and they proliferated at a
lower rate than wild-type (Figure 7C). The kinetics of
transmigration and cytospin preparations showing poor
mitotic activity in transmigrated a4-null cells compared
with wild-type suggest that both processes, transmigra-
tion and proliferation, are affected by the absence of a4
integrins. Moreover, the efficiency in obtaining pre-B
cell lines from a4-null fetal livers was consistently much
lower, and it was not possible to obtain clones from a4-
null cell lines by limiting dilution because the cells failed
to expand (data not shown). From these in vitro data,
we conclude that a4-null cells from erythroid and B
lymphoid lineages have hampered ability for transmigra-
tion through the stroma, and this may result in lower
rates of cellular proliferation.
Discussion
In this report, analyses of a4-null mutant and chimeric
mice during embryonic development have shown that
(1) a4 integrins are not essential for erythropoiesis in
the yolk sac; (2) multipotent definitive progenitors can
migrate to fetal liver, thymus, bone marrow, and spleen
in the absence of a4 integrins; (3) terminal differentiation
of erythroid, myeloid, and lymphoid lineages can occur
in the absence of a4 integrins, albeit inefficiently; and
(4) a4 integrins are essential for maintenance of efficient
development of multilineage progenitors in the fetal
liver, bone marrow, and spleen microenvironments,
probably by regulating transmigration and proliferation
of progenitors.
a4 Integrins and Erythroid Development
Several reports had suggested roles for a4 integrins
during erythropoiesis (Hanspal, 1997). We have shown
that erythropoiesis in the yolk sac can occur in the ab-
sence of a4 integrins, indicating that a4 integrins are not
essential for commitment and terminal differentiation of
erythroid progenitors. Moreover, a4-null erythroid pro-
genitors can migrate to fetal liver, bone marrow, and
experiment was run in triplicate. One experiment out of two is shown.
Bar, 330 mm.
(B and C) Pre-B lymphoid cell lines were derived from E12 fetal
livers from wild-type and a4-null embryos in the presence of IL-7.
Pre-B cell lines were plated on the bone marrow stromal cell line
CBR-BM, L#19 and their transmigration (B) and proliferation (C)
behavior recorded after washing cells in suspension. As shown, a4-
null pre-B cells migrate underneath the stroma very poorly in con-
Figure 7. Erythroid and B Lymphoid Progenitors Fail to Transmi- trast with wild-type cells. Proliferation on bone marrow stroma was
grate and Proliferate in the Absence of a4 Integrins also tested; pre-B cells were separated into two categories, wash-
(A) In vitro erythropoiesis assays performed with fetal liver cells from able, i.e., cells in suspension and cells weakly attached to the
wild-type and a4-null embryos at E12. At day 1, small groups of stroma, and nonwashable, cells located underneath the stroma and
erythroid progenitors attached to the stroma are observed in both the few strongly attached to the stroma. Results show that a4-null
wild-type and null cultures. After 4 days, a4-null cells give rise only pre-B cells transmigrate very poorly and also they do not proliferate
to tiny reddish colonies and no cells are observed underneath the as well as wild-type. Experiments were run in duplicate, and SD
stroma in contrast to wild-type cells that differentiate into larger was less than 5%. The mean is represented. One experiment out
and redder colonies with plenty of cells lying underneath. Each of three similar ones is shown. Bar, 166 mm.
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spleen as demonstrated by in vitro colony assays and 1992). However, little was known about the in vivo roles
of a4 integrins in the development of these lineages.flow cytometry. In these microenvironments, the pro-
genitors can differentiate without a4 integrins, but only Intrautero injection of antibodies against a4 integrins
revealed only a minor decrease in the number of myeloidlow yields of mature erythrocytes are obtained, with the
defect being more evident in bone marrow, and spleen. and lymphoid colonies at birth (Hamamura et al., 1996).
We report here that terminal differentiation of T andThese in vivo data point to a defect in proper expansion
of erythroid populations. This is supported by in vitro B lymphocytes, monocytes, and granulocytes is possi-
ble in the absence of a4 integrins during fetal develop-data showing defective transmigration and proliferation
of erythroid progenitors in the absence of a4 integrins. ment in accord with our previous data (Arroyo et al.,
1996). However, although a4-deficient multipotent pro-Interestingly, the expression pattern of a4 integrins, be-
ing expressed on early erythroid progenitors (BFU-e and genitors are detected in the fetal liver, bone marrow,
and spleen at different stages of embryonic develop-CFU-e) and downregulated later, conforms with the
stages at which high rate of proliferation occurs. These ment, only small percentages of a4-null progenitors
complete successful differentiation, indicating that a4results provide an explanation for in vitro data showing
an inhibition of erythroid development by anti-a4 inte- integrins are required for efficient myeloid and B lymphoid
development in vivo. As for the erythroid lineage, thegrin antibodies (Yanai et al., 1994) and in vivo data show-
ing perinatal anemia in pups from mice injected with defects in B lymphoid and myeloid development be-
come more obvious after birth when bone marrow takesantibodies against a4 integrins (Hamamura et al., 1996).
Macrophage-erythroid progenitor interactions in eryth- the major role in hematopoietic development. A low
steady-state level of myeloid differentiation is consis-roblastic islands may be mediated by a4 integrin-
VCAM-1 (Sadahira et al., 1995). In the absence of a4 tently present in the bone marrow in the absence of
a4 integrins, in contrast to B lymphoid and erythroidintegrins, erythroblastic island formation would be de-
fective, and this might explain the defects in prolifera- differentiation that is practically undetectable. These dif-
ferences among lineages might be due to differencestion, the smaller size of the cellular aggregates observed
in a4-null fetal livers, and the fragility of a4-null fetal in compensatory mechanisms or differences in the re-
newal rate. This agrees with reports that anti-a4 integrinlivers compared with wild-types. It is possible that FN
also participates in these interactions, since it has been antibodies block B cell development but only delay my-
eloid development in vitro (Miyake et al., 1991) and withreported that anti-VCAM-1 antibodies blocked only par-
tially (Yanai et al., 1994). Antibodies against a4 integrins the previous analysis of adult a4-null chimeric mice in
which a certain population of a4-deficient monocytescan block attachment, migration, and differentiation on
stroma or FN of erythroid progenitors in vitro in contrast was present in blood (Arroyo et al., 1996).
Results obtained with pre-B cell lines show that a4to anti-a5 integrin antibodies that block only attachment
(Yanai et al., 1994; Goltry and Patel, 1997). Our data integrins are required for proper attachment, transmi-
gration, and proliferation of B cell precursors likely byconfirm that a4-null erythroid progenitors cannot trans-
migrate through stroma and differentiate efficiently al- mediating progenitor-stroma interactions. The ligand in-
volved in these processes seems to be FN rather thanthough attachment seems to be less affected, likely due
to a5 integrins. Interestingly, no defects in erythroid de- VCAM-1 since no major defects in hematopoiesis are
found in VCAM-1-null mice (Friedrich et al., 1996b). Lym-velopment are found in a5-null chimeric mice, sug-
gesting that in vivo roles for a4 and a5 integrins are in phocyte transmigration is directed by chemokines that
can also activate integrin functions in lymphocytes. Itfact distinct during erythroid development (Arroyo et al.,
unpublished data). is possible that the absence of a4 integrins decreases
the responsiveness of lymphoid cells to chemokines, inFinally, we have shown that erythroid development is
impaired in some microenvironments (fetal liver, bone particular to SDF-1/CXCR4 complex. The phenotypes
of knockout mice for SDF-1 and its receptor CXCR4marrow, and spleen) but not others (yolk sac). It has
recently been shown how the environment can provide with defects in B cell lymphopoiesis and bone marrow
myelopoiesis (Nagasawa et al., 1996; Tachibana et al.,the specific signals for determining the fate of hemato-
poetic progenitors (Geiger et al., 1998). Erythrocytes 1998) recall the defects observed in the absence of a4
integrins. It would be interesting to investigate if a4originating in the yolk sac are nucleated in contrast to
nonnucleated definitive erythrocytes, and interactions integrins are targets for chemokine hematopoietic func-
with the stroma might regulate the enucleation process, tions in vivo. Modulation by SDF-1 of the VLA-4/VCAM-1
suggesting that adhesion receptors might be differen- pathway in migration of progenitors through bone mar-
tially required (Hanspal, 1997). It is also known that sev- row endothelial cells has recently been reported (Imai
eral growth signal pathways act in synergy with integrins et al., 1999).
(Clark and Brugge, 1995). Thus, synergism with other Since the severity of the developmental defects differ
proteins such as Epo, c-kit, c-myb, and TEL, whose in the diverse lineages analyzed (erythroid, myeloid, and
requirements are differentially regulated in yolk sac ver- B lymphoid), there might be partial compensation by
sus fetal liver hematopoiesis, might also account for the other surface receptors. Since both a4 and a5 integrins
observed differences in a4 integrin dependence. have been implicated in transmigration of lymphoma
cells (Miyake et al., 1992), it is possible that a5 integrins
might compensate for part of the defect. aLb2 is ex-a4 Integrins in Myeloid and Lymphoid Development
pressed on erythroblasts and on B lymphocytes, andIn vitro experiments with antibodies had suggested im-
aLb2, aMb2, and aXb2 are on myeloid cells. This expres-portant roles for a4 integrins during lymphoid and my-
eloid development (Miyake et al., 1991; Ryan et al., sion pattern might explain differential compensation.
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Moreover, two new integrins, aDb2 and a9b1, have re- of c-myb mutant mice (Mucenski et al., 1991) and TEL-
null chimeric mice (Wang et al., 1998) recall the defectscently been reported to bind VCAM-1, raising the possi-
observed in the absence of a4 integrins. Thus, a4 inte-bility of compensation for binding to this ligand (Grayson
grins might be acting as important in vivo targets foret al., 1998; Taooka et al., 1999).
c-myb and/or TEL. The in vivo roles of a4 integrins inWe had previously shown a switch in a4 integrin re-
progenitor proliferation highlight the importance thatquirements for T lymphocyte development after birth
these adhesion receptors might have in leukemogenesis(Arroyo et al., 1996). Here, we show that T cell progeni-
(Schwartz, 1997).tors migrate to the thymus and differentiate efficiently
We propose a working model for the roles of a4 inte-into all subsets of T lymphocytes during embryonic de-
grins in regulating hematopoiesis. Hematopoietic pro-velopment. Some results even suggest that a4-deficient
genitors normally seed and attach to the stroma. Weiss-T cell progenitors might have a certain advantage for T
man (1994) distinguishes three compartments within thecell differentiation, but this point deserves further inves-
stroma for self-renewal, expansion, and maturation oftigation. Our results do not confirm previous in vitro
progenitors, and distinct elements of the stromal micro-data on a4 integrin roles on thymocyte attachment and
environment controlling growth and differentiation ofdifferentiation (Crisa et al., 1996). There might be differ-
progenitors have recently been identified (Aiuti et al.,ent requirements in vitro and in vivo or compensation
1998). Differential signaling in these stromal compart-by other receptors in vivo. The interesting point is that
ments might involve the secretion of soluble factorsa4-deficient hematopoietic progenitors can proliferate
such as cytokines and chemokines as well as differentand differentiate well in the thymic microenvironment
stroma-progenitor cell interactions. The balance amongbut not in fetal liver, bone marrow, or spleen. This might
all these signals (reviewed by Ogawa, 1993) and thebe explained by regulation of transmigration of thymo-
competition for the niches among different progenitorscytes by specific thymic chemokines (Vicari et al., 1997;
would determine the fate of the various committed he-Kim et al., 1998) or by different requirements for prolifer-
matopoietic progenitors. In the expansion stroma, pro-ation of thymocytes independent of transmigration.
genitors would transmigrate in response to chemokines,
which might also facilitate this process by activatingA Model for Regulation of the Proliferation/
adhesion receptors such as integrins (Coulombel et al.,Differentiation Balance of Hematopoietic
1997). In that niche, progenitors proliferate in contactProgenitors through a4 Integrins
with extracellular matrix proteins such as fibronectin
a4 integrins had been suggested to play roles in mi-
and growth factors presented by the proteoglycans.gration, attachment, transmigration, proliferation, and
After this expansion stage, progenitors continue differ-differentiation of hematopoietic progenitors in vitro (re-
entiation into mature cells under the influence of differ-viewed by Coulombel et al., 1997). The complex pheno-
ent cytokines in the maturation compartment. In ourtype we observe in vivo in the absence of a4 integrins
model, a4 integrins would act as a retention signal forsuggests that one or more of these processes are im-
progenitors (likely at different stages depending on thepaired in vivo.
lineage) to remain in the expansion compartment. In
We have shown that a4 integrins are not essential for
the absence of a4 integrins, two major steps would be
migration of progenitors to the different hematopoietic
impaired: first, the response to cytokines and chemo-
organs. This is in contrast with the defect in migration
kines and subsequent attachment and transmigration
to fetal liver observed in the absence of b1 integrins beneath the stroma, and second, proliferation mediated
(Hirsch et al., 1996), suggesting that other b1 heterodi- by contact with fibronectin and growth factors. As a
mers might be involved, and with reports suggesting dif- consequence, a4-deficient progenitors would detach
ferential roles for a4 integrins in lodgment of progenitors prematurely, skipping the expansion phase, and shift
in bone marrow and spleen (Papayannopoulou et al., toward differentiation. This might result in low numbers
1995). It is possible that a4 integrins play a role during of progenitors involved in hematopoiesis and lower
those processes, but our data demonstrate that their yields of mature cells. Defects in multilineage develop-
functions are not essential and other receptors can sub- ment may be more evident at postnatal stages because
stitute in their absence. a4 integrins might be differentially required in bone mar-
We report here that transmigration of progenitors row and spleen versus fetal liver environments or be-
through the stroma is impaired in the absence of a4 cause the rate of production of hematopoietic cells is
integrins and that progenitor cells lacking a4 integrins higher after birth, and defective competition and prolifer-
do not proliferate as efficiently as wild-type. Previous ation would become more evident. The differences in
reports had suggested that a4 integrins could be in- the severity of the defects in various lineages might be
volved in regulation of proliferation of progenitors (Mo- due to different stages of differentiation being affected
ritz et al., 1994; Levesque et al., 1996), and it has recently depending on the lineage or to substitution by other
been reported that fibronectin, particularly the CS-1 re- receptors. It may be important to keep these defects in
gion that binds a4 integrins, facilitates and increases mind since anti-a4 integrin inhibitors are being used
proliferation of hematopoietic progenitors (Schofield et for therapy of chronic inflammatory diseases (Lobb and
al., 1998; Yokota et al., 1998). Synergism between inte- Hemler, 1994).
grins and growth factors such as c-kit has been reported In summary, we describe how a4 integrin-mediated
(Papayannopoulou et al., 1998). It has also been shown interactions are essential for normal expansion of hema-
that the protooncogenes c-myb and Ets family members topoietic progenitors in vivo. These data point to a4
act synergistically to regulate a4 gene promoter in he- integrins as major regulators of the proliferation/differ-
entiation balance during hematopoiesis.matopoietic cells (Postigo et al., 1997). The phenotypes
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Experimental Procedures Colony Assays
For yolk sac progenitor assays, embryos were used for genotyping.
Yolk sacs were incubated in PBS with 20% FBS and 0.1% collage-Mice
a4 integrin mutant mice were generated (Yang et al., 1995), and nase (Sigma) at 378C for 1 hr. Cells were disaggregated by passage
through a 22-gauge needle (Wang et al., 1998). The yield from eachchimeric mice were obtained by injection of a4-null or wild-type ES
cells into blastocysts from C57BL or RAG-2-deficient mice (Arroyo yolk sac was 1±5 3 104 cells. Cells (5 3 103) of each yolk sac were
plated in IMDM plus 0.9% a-methylcellulose (StemCell), 30% FBS,et al., 1996). Embryos were dissected, and either the yolk sac or
the embryo was used for colony assays and genotyping by PCR 1% BSA, 2 mM b-mercaptoethanol, and growth factors. For ery-
throid colonies (BFU-e), 2 units/ml erythropoietin (Epo) and 20 ng/(Yang et al., 1995).
ml recombinant c-kit ligand were added. For CFU-mix colonies, 2
units/ml erythropoietin (Epo), 20 ng/ml recombinant c-kit ligand,
Cells 12.5 ng/ml IL-3, and 12.5 ng/ml IL-6 were added. Epo was from
CBR-BM, L#19 bone marrow stromal cell line (Friedrich et al., 1996a) Amgen and the rest of the cytokines from R&D Systems.
was kindly provided by Dr. J. C. GutieÂ rrez-Ramos (Millenium). Cells For fetal liver colony assays, single-cell suspensions from fetal
were maintained in culture in Iscove's modified Dulbecco's medium livers at different stages were plated in the same medium as for
([IMDM]; GIBCO) plus 10% fetal bovine serum (FBS) and b-mercap- yolk sacs. For erythroid colonies (CFU-e), 2 units/ml Epo were used.
toethanol at the permissive temperature 338C. For fetal liver colony assays from chimeric embryos, the same
system was used but colonies were quantitated in the absence and
presence of G418 (1.5 mg/ml). For BFU-e, GM-CSF instead of IL-6
Hemoglobin Analysis was used.
Blood was obtained from the umbilical cord of embryos or from the
heart or eye in pups and adult mice in tubes containing EDTA.
Hemoglobins were analyzed by cellulose acetate electrophoresis of Erythropoiesis In Vitro
hemolysates treated with cystamine (Whitney, 1978). This method CBR-BM, L#19 bone marrow stromal cell line was grown to form a
permits the discrimination of the codominant mouse hemoglobin monolayer in a 24-well plate (Falcon) at 338C and then transferred
ªsingleº (Hbbs) allele present in C57BL mouse strain and ªdiffuseº to 378C the night prior to the assay. Cocultivation of erythroid pro-
(Hbbd and Hbbp) alleles present in 129Sv strain. The sensitivity of genitor cells on stromal cells was performed as described (Yanai et
the assay is 1%±5% (data not shown). Densitometric analysis of the al., 1994). Single cell preparations from E12 livers from wild-type or
gels was performed using ID-multilane Scan of the IS-1000 Digital a4-null embryos were suspended in IMDM with 30% heat-inacti-
Imaging System (Alpha Innotech). vated FBS, 0.4% methylcellulose, 1% BSA, 100 mM/L 2-mercapto-
ethanol, and 0.1 U/mL Epo, and cultured on the stromal cells for 4
days.
GPI Assays
Glucose-phosphate-isomerase assays were performed as de-
scribed (Yang et al., 1996). In brief, samples were lysed by four Establishment of Pre-B Cell Lines
cycles of freezing and thawing, and GPI isoforms were analyzed Establishment of pre-B cell lines was as described (Rolink et al.,
by cellulose acetate electrophoresis and detected by applying an 1991). Fetal liver cells from E12 wild-type or a4-null embryos were
agarose gel containing fructose-6-phosphate, NDP, MTT, PMS, and cultured at 5 3 104 to 2 3 105/ml in IMDM plus 30% FBS and 2-mer-
glucose-6-phosphate dehydrogenase (all reagents from Sigma) at captoethanol on a confluent layer of CBR-BM, L#19 stromal cell
room temperature. Pictures were taken and densitometry performed line in the presence of 1 ng/ml IL-7 (R&D Systems). After 3±4 days,
using the IS-1000 Digital Imaging System. This method permits the when the pre-B cells were grown to a semiconfluent layer on the
discrimination of the isoforms GPI-Iaa and GPI-Ibb present in 129Sv stromal cells, they were transferred from 96-well plates to a new
and C57BL strains, respectively. stromal cell layer in a 24-well plate and again to 6-well plates when
they reached semiconfluency (3±4 days). Cells were fed every 3±4
days and transferred to new stromal cell layers when old stroma
Flow Cytometry and Sorting looked exhausted. Cloning of pre-B cell lines established under
The following monoclonal antibodies from PharMingen were used these conditions was done by limiting dilution on stromal cell layers
for flow cytometry: PE-conjugated anti-mouse CD90.2 (Thy-1.2, 53- in 96-well flat-bottomed plates. a4-null pre-B cell lines could not be
2.1), PE-conjugated anti-mouse CD4 (L3T4, RM4-5), PE-conjugated cloned by limiting dilution because, although growth of single cells
anti-mouse CD45R/B220 (RA3-6B2), FITC-conjugated anti-mouse were obtained, they were not able to expand.
IgM (R6-60.2), PE-conjugated anti-mouse CD11b (Mac-1 a chain,
M1/70), PE-conjugated anti-mouse Ly-6G (Gr-1, RB6-8C5), PE-con-
jugated anti-mouse TER-119, FITC-conjugated anti-mouse CD49d Statistical Analysis
(integrin a4 chain, R1-2), FITC-conjugated anti-mouse CD45.2 (Ly- Data from mice of the different phenotypes were analyzed and com-
5.2,104), and FITC-conjugated anti-mouse Ly-9.1 (30C7). Single cell pared for statistically significant differences using the Student's t
suspensions were incubated with purified anti-mouse CD32/CD16 test.
(PharMingen) to block Fc receptors and with an appropriate dilution
of the different antibodies at 48C. The samples were washed twice
and resuspended in PBS. Dead cells were excluded by propidium Acknowledgments
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